Literature DB >> 23782969

Central or peripheral catheters for initial venous access of ICU patients: a randomized controlled trial.

Jean-Damien Ricard1, Laurence Salomon, Alexandre Boyer, Guillaume Thiery, Agnes Meybeck, Carine Roy, Blandine Pasquet, Eric Le Mière, Didier Dreyfuss.   

Abstract

OBJECTIVES: The vast majority of ICU patients require some form of venous access. There are no evidenced-based guidelines concerning the use of either central or peripheral venous catheters, despite very different complications. It remains unknown which to insert in ICU patients. We investigated the rate of catheter-related insertion or maintenance complications in two strategies: one favoring the central venous catheters and the other peripheral venous catheters.
DESIGN: Multicenter, controlled, parallel-group, open-label randomized trial.
SETTING: Three French ICUs. PATIENTS: Adult ICU patients with equal central or peripheral venous access requirement. INTERVENTION: Patients were randomized to receive central venous catheters or peripheral venous catheters as initial venous access. MEASUREMENTS AND
RESULTS: The primary endpoint was the rate of major catheter-related complications within 28 days. Secondary endpoints were the rate of minor catheter-related complications and a composite score-assessing staff utilization and time spent to manage catheter insertions. Analysis was intention to treat. We randomly assigned 135 patients to receive a central venous catheter and 128 patients to receive a peripheral venous catheter. Major catheter-related complications were greater in the peripheral venous catheter than in the central venous catheter group (133 vs 87, respectively, p=0.02) although none of those was life threatening. Minor catheter-related complications were 201 with central venous catheters and 248 with peripheral venous catheters (p=0.06). 46% (60/128) patients were managed throughout their ICU stay with peripheral venous catheters only. There were significantly more peripheral venous catheter-related complications per patient in patients managed solely with peripheral venous catheter than in patients that received peripheral venous catheter and at least one central venous catheter: 1.92 (121/63) versus 1.13 (226/200), p<0.005. There was no difference in central venous catheter-related complications per patient between patients initially randomized to peripheral venous catheters but subsequently crossed-over to central venous catheter and patients randomized to the central venous catheter group. Kaplan-Meier estimates of survival probability did not differ between the two groups.
CONCLUSION: In ICU patients with equal central or peripheral venous access requirement, central venous catheters should preferably be inserted: a strategy associated with less major complications.

Entities:  

Mesh:

Year:  2013        PMID: 23782969     DOI: 10.1097/CCM.0b013e31828a42c5

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Authors:  Silvia Calviño Günther; Carole Schwebel; Rebecca Hamidfar-Roy; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Clémence Minet; Leïla Potton; Jean-Charles Cartier; Aurelien Vésin; Magalie Chautemps; Lenka Styfalova; Stephane Ruckly; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

2.  The CVC and CRBSI: don't use it and lose it!

Authors:  K B Laupland; D Koulenti; C Schwebel
Journal:  Intensive Care Med       Date:  2017-12-26       Impact factor: 17.440

3.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

4.  Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings.

Authors:  Ajay Padmanaban; Ramesh Venkataraman; Senthilkumar Rajagopal; Dedeepiya Devaprasad; Nagarajan Ramakrishnan
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-11-07

Review 5.  Management of cardiogenic shock complicating myocardial infarction.

Authors:  Alexandre Mebazaa; Alain Combes; Sean van Diepen; Alexa Hollinger; Jaon N Katz; Giovanni Landoni; Ludhmila Abrahao Hajjar; Johan Lassus; Guillaume Lebreton; Gilles Montalescot; Jin Joo Park; Susanna Price; Alessandro Sionis; Demetris Yannopolos; Veli-Pekka Harjola; Bruno Levy; Holger Thiele
Journal:  Intensive Care Med       Date:  2018-05-16       Impact factor: 17.440

6.  Consensus on circulatory shock and hemodynamic monitoring. Task force of the European Society of Intensive Care Medicine.

Authors:  Maurizio Cecconi; Daniel De Backer; Massimo Antonelli; Richard Beale; Jan Bakker; Christoph Hofer; Roman Jaeschke; Alexandre Mebazaa; Michael R Pinsky; Jean Louis Teboul; Jean Louis Vincent; Andrew Rhodes
Journal:  Intensive Care Med       Date:  2014-11-13       Impact factor: 17.440

7.  Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events.

Authors:  Mikael Hallengren; Per Åstrand; Staffan Eksborg; Hans Barle; Claes Frostell
Journal:  PLoS One       Date:  2017-08-24       Impact factor: 3.240

8.  Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis.

Authors:  Victoria S Owen; Brianna K Rosgen; Stephana J Cherak; Andre Ferland; Henry T Stelfox; Kirsten M Fiest; Daniel J Niven
Journal:  Crit Care       Date:  2021-04-16       Impact factor: 9.097

9.  Critically ill cancer patient's resuscitation: a Belgian/French societies' consensus conference.

Authors:  Anne-Pascale Meert; Sebastian Wittnebel; Stéphane Holbrechts; Anne-Claire Toffart; Jean-Jacques Lafitte; Michael Piagnerelli; France Lemaitre; Olivier Peyrony; Laurent Calvel; Jean Lemaitre; Emmanuel Canet; Alexandre Demoule; Michael Darmon; Jean-Paul Sculier; Louis Voigt; Virginie Lemiale; Frédéric Pène; David Schnell; Etienne Lengline; Thierry Berghmans; Laurence Fiévet; Christiane Jungels; Xiaoxiao Wang; Ionela Bold; Aureliano Pistone; Adriano Salaroli; Bogdan Grigoriu; Dominique Benoit
Journal:  Intensive Care Med       Date:  2021-09-20       Impact factor: 17.440

10.  REstricted Fluid REsuscitation in Sepsis-associated Hypotension (REFRESH): study protocol for a pilot randomised controlled trial.

Authors:  Stephen P J Macdonald; David McD Taylor; Gerben Keijzers; Glenn Arendts; Daniel M Fatovich; Frances B Kinnear; Simon G A Brown; Rinaldo Bellomo; Sally Burrows; John F Fraser; Edward Litton; Juan Carlos Ascencio-Lane; Matthew Anstey; David McCutcheon; Lisa Smart; Ioana Vlad; James Winearls; Bradley Wibrow
Journal:  Trials       Date:  2017-08-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.